NGP
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NGP Trademark

Serial Number: 79411087 • Registration: 7797780

NGP is a trademark filed by Sichuan Neo-Green Pharmaceutical Technology Develo on April 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sichuan Neo-Green Pharmaceutical Technology Develo

No. 279 Donghe East Road, Zhihe Town, Pengzhou Cit

Entity Type: 99

Trademark Details

Filing Date

April 19, 2024

Registration Date

May 20, 2025

Published for Opposition

April 1, 2025

Goods & Services

Vitamin preparations; medicinal oils, other than essential oils; nutraceuticals for the treatment of diabetes; medicines made of chinese traditional medicinal herbs; medicinal herbal preparations; chinese traditional medicinal herbs; medicated toothpaste; mentholated ointment for medical use; medicated oral care gels; chemical preparations for the diagnosis of pregnancy; plant and herb extracts, other than essential oils, for medicinal purposes; medicinal herb extracts, other than essential oils; honey-based ointment for medical purposes; medicine tonics, namely, substances that invigorate bodily conditions in the nature of medicinal drinks, medicinal oils other than essential oils and medicinal roots; medicated tonics for the treatment of hair, skin, muscles, organs, bones and immune systems; herbal extracts, other than essential oils, for medical purposes; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; plant extracts, other than essential oils, for pharmaceutical purposes; mineral preparations for medical purposes; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, epstein-barr (EB) viruses, hormonal diseases, allergic disorder, immune disorder, TORCH infections and immunoglobulin diseases; vitamin tablets; antibiotic tablets; herbal tinctures for medical purposes; herbal pills for the treatment of diabetes; medicinal tea; medicinal herbs; medicated hair care preparations; medicinal herbal extracts, other than essential oils, for medical purposes; mineral dietary supplements; nutritional supplements; antibiotics for veterinary purposes; dietary supplements for animals.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 14, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 27, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2026 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 23, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 23, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 21, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 20, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2025 TROA
REFUSAL PROCESSED BY IB
Jan 10, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 20, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 20, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 9, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 4, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 28, 2024 REPR